Rick Matthews: Venous Thromboembolism Treatment Isn’t the Same For Everyone
Rick Matthews, Sr. Vascular Consultant at Argon Medical Devices, Inc. and Radiology Instructor at Pima Medical Institute, shared a post on LinkedIn:
”VTE treatment isn’t one-size-fits-all.
When evaluating a patient with DVT, the decision to intervene should start with the fundamentals: anatomy, chronicity, symptom burden, and patient risk.
Technology continues to evolve, but good clinical decision-making still starts with understanding the patient and choosing the right strategy for the individual situation.
The goal isn’t simply to remove clot — it’s to make the right treatment decision for the right patient.
What factors weigh most heavily in your decision-making when evaluating VTE patients?”
Find more posts featuring Rick Matthews on Hemostasis Today.
-
Oct 24, 2026, 12:27Emeka Patrick Chukwuka: Ferritin Falls First – Iron Deficiency Before Anaemia
-
Oct 24, 2026, 11:57Priyanka Kandalgaokar: Sharing India’s Patient Advocacy Journey at MPN Horizon 2026
-
Oct 24, 2026, 11:40Uli Schotten: Coagulation Factors May Influence Cardiac Remodelling
-
Oct 24, 2026, 11:20Edward Lee Carter: Anticoagulation After Intracranial Hemorrhage – Encouraging Data, but an Unresolved Tradeoff
-
Oct 24, 2026, 11:16Aram Hovhannisyan: New Evidence on CAT from the THEO Study
-
Oct 24, 2026, 10:49Shahram Kordasti: Investigating Novel Immune Targets in MPN
-
Oct 24, 2026, 10:32Amber Yates: A Major Milestone for the RISE UP Phase 3 Study
-
Oct 24, 2026, 10:22Emmanuel J Favaloro: Laboratory Diagnostics in Hemostasis – The Final 2026 Issue
-
Oct 24, 2026, 10:13Rana Al-Hrout: Vitamin B12 Deficiency – Neurological Symptoms Without Anemia